A Pattern Approach to Focal White Matter Hyperintensities on Magnetic Resonance Imaging

Radiologic Clinics of North America

Volumn 52, Issue 2, 2014, Pages 241-261

  Kanekar, Sangam ^a   Devgun, Puneet ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Acute disseminated encephalomyelitis; CNS vasculitis; Focal white matter hyperintensity; Lyme; Multiple sclerosis; Sarcoid

Indexed keywords

ACUTE DISSEMINATED ENCEPHALOMYELITIS; CADASIL; CENTRAL NERVOUS SYSTEM VASCULITIS; DIFFERENTIAL DIAGNOSIS; FOCAL WHITE MATTER HYPERINTENSITY; HUMAN; LACUNAR STROKE; LYME DISEASE; MIGRAINOUS ISCHEMIA; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIATION SICKNESS; REVIEW; SARCOIDOSIS; VIRCHOW ROBIN SPACE; WATERSHED INFARCTION; WHITE MATTER LESION;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; CNS VASCULITIS; FOCAL WHITE MATTER HYPERINTENSITY; LYME; MULTIPLE SCLEROSIS; SARCOID;

DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; RISK FACTORS;

EID: 84894621692     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2013.11.010     Document Type: Review

References (49)

1. Heier L.A., Bauer C.J., Schwartz L., et al. Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol 1989, 10(5):929-936.
2. Stephens T., Parmar H., Cornblath W. Giant tumefactive perivascular spaces. JNeurol Sci 2008, 266(1-2):171-173.
3. Diamond S., Bigel M.E., Silberstein S., et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007, 47:355-363.
4. Seneviratne U., Chong W., Billimoria P.H. Brain white matter hyperintensities in migraine: clinical and radiological correlates. Clin Neurol Neurosurg 2013, 115(7):1040-1043.
5. Kruit M.C., van Buchem M.A., Launer L.J., et al. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 2010, 30:129-136.
6. Rossato G., Adami A., Thijs V.N., et al. Cerebral distribution of white matter lesions in migraine with aura patients. Cephalalgia 2010, 30:855-859.
7. Smith K.J., McDonald W.I. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 1999, 354(1390):1649-1673.
8. Nusbaum A., Rapalino O., Fung K., et al. White matter disease and inherited metabolic disorders. Magnetic resonance imaging of the brain and spine 2009, vol. 1:343-444. Williams & Wilkins, Philadelphia. 4th edition.
9. Debouverie M., Pittion-Vouyovitch S., Louis S., et al. Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 2008, 15(9):916-921.
10. Polman C.H., Reingold S.C., Banwell B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69(2):292-302.
11. Traboulsee A., Li D.K. Conventional MR imaging. Neuroimaging Clin N Am 2008, 18(4):651-673.
12. Menge T., Hemmer B., Nessler S., et al. Acute disseminated encephalomyelitis: an update. Arch Neurol 2005, 62:1673-1680.
13. Rossi A. Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am 2008, 18(1):149-161.
14. Balasubramanya K.S., Kovoor J.M., Jayakumar P.N., et al. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology 2007, 49:177-183.
15. Bizzi A., Ulug A.M., Crawford T.O., et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001, 22:1125-1130.
16. Salvarani C., Brown R.D., Calamia K.T., et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007, 62:442-451.
17. Albayram S., Saip S., Hasiloglu Z.I., et al. Evaluation of parenchymal neuro-Behçet disease by using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2011, 32(6):1050-1055.
18. Marks M.P. Cerebral ischemia and infarction. Magnetic resonance imaging of the brain and spine 2009, vol. 1:772-825. Williams & Wilkins, Philadelphia. 4th edition.
19. Horowitz D.R., Tuhrim S., Weinberger J.M., et al. Mechanisms in lacunar infarction. Stroke 1992, 23:325-327.
20. Ay H., Oliveira-Filho J., Buonanno F., et al. Diffusion- weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke 1999, 30:2644-2650.
21. Momjian-Mayor I., Baron J.C. The pathophysiology of watershed infarction in internal carotid artery: review of cerebral perfusion studies. Stroke 2005, 36:567-577.
22. Bladin C.F., Chambers B.R. Clinical features, pathogenesis, and computed tomographic characteristics of internal watershed infarction. Stroke 1993, 24:1925-1932.
23. Bladin C.F., Chambers B.R. Frequency and pathogenesis of hemodynamic stroke. Stroke 1994, 25:2179-2182.
24. Tournier-Lasserve E., Joutel A., Melki J., et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993, 3:256-259.
25. Ruchoux M.M., Maurage C.A. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. JNeuropathol Exp Neurol 1997, 56:947-964.
26. Gladstone J.P., Dodick D.W. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist 2005, 11:19-29.
27. Yousry T.A., Seelos K., Mayer M., et al. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol 1999, 20(1):91-100.
28. Auer D.P., Schirmer T., Heidenreich J.O., et al. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study. Neurology 2001, 56(5):635-642.
29. Delaney P. Neurological manifestations in sarcoidosis: review of the literature, with report of 23 cases. Ann Intern Med 1977, 87:336-345.
30. Stern B.J., Krumholz A., Johns C., et al. Sarcoidosis and its neurological manifestations. Arch Neurol 1985, 42:909-917.
31. Colby T.V. Interstitial lung diseases. Pathology of the lung 1995, 589-737. Thieme Medical Publishers, New York. 2nd edition. W. Thurlbeck, A. Churg (Eds.).
32. Smith J.K., Matheus M.G., Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol 2004, 182(2):289-295.
33. Agarwal R., Sze G. Neuro-Lyme disease: MR imaging findings. Radiology 2009, 253(1):167-173.
34. Hengge U.R., Tannapfel A., Tyring S.K., et al. Lyme borreliosis. Lancet Infect Dis 2003, 3(8):489-500.
35. Rupprecht T.A., Koedel U., Fingerle V., et al. The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med 2008, 14(3-4):205-212.
36. Agosta F., Rocca M.A., Benedetti B., et al. MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis. AJNR Am J Neuroradiol 2006, 27(4):892-894.
37. Vanzieleghem B., Lemmerling M., Carton D., et al. Lyme disease in a child presenting with bilateral facial nerve palsy: MRI findings and review of the literature. Neuroradiology 1998, 40(11):739-742.
38. Kochling J., Freitag H.J., Bollinger T., et al. Lyme disease with lymphocytic meningitis, trigeminal palsy and silent thalamic lesion. Eur J Paediatr Neurol 2008, 12(6):501-504.
39. Berger J.R., Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. JNeurovirol 1995, 1:5-18.
40. Thurnher M.M., Thurnher S.A., Mühlbauer B., et al. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI. Neuroradiology 1997, 39:611-618.
41. Langer-Gould A., Atlas S.W., Green A.J., et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. NEngl J Med 2005, 353:375-381.
42. Whiteman M.L., Post M.J., Berger J.R., et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993, 187:233-240.
43. Chang L., Ernst T., Tornatore C., et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy: a proton magnetic resonance spectroscopy study. Neurology 1997, 48:836-845.
44. Iranzo A., Moreno A., Pujol J., et al. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. JNeurol Neurosurg Psychiatry 1999, 66:520-523.
45. Vernooij M.W., Smits M. Structural neuroimaging in aging and Alzheimer's disease. Neuroimaging Clin N Am 2012, 22(1):33-55.
46. Galluzzi S., Lanni C., Pantoni L., et al. White matter lesions in the elderly: pathophysiological hypothesis on the effect on brain plasticity and reserve. JNeurol Sci 2008, 273(1-2):3-9.
47. Sheline G. Radiation therapy of brain tumors. Cancer 1977, 39:873-881.
48. Postma T.J., Klein M., Verstappen C.C., et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology 2002, 59:121-123.
49. Ball W.S., Prenger E.C., Ballard E.T. Neurotoxicity of radio/chemotherapy in children: pathologic and MR correlation. AJNR Am J Neuroradiol 1992, 13(2):761-776.